Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular and Cellular Endocrinology|November 7, 2016
MicroRNAs in parathyroid physiopathologyV Vaira, C Verdelli, I Forno, et al.Journal of Endocrinological Investigation|January 12, 2015
MicroRNA deregulation in parathyroid tumours suggests an embryonic signatureC Verdelli, I Forno, V Vaira, et al.Oncogene|October 31, 2006
Regulation of survivin expression by IGF-1/mTOR signalingV Vaira, C W Lee, H L Goel, et al.British Journal of Cancer|January 31, 2013
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesotheliomaD J Pinato, F A Mauri, T Lloyd, et al.Oncogene|June 7, 2011
miR-296 regulation of a cell polarity-cell plasticity module controls tumor progressionV Vaira, A Faversani, T Dohi, et al.Cancer Letters|August 14, 2016
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivationE Peverelli, E Giardino, D Treppiedi, et al.Endocrine-Related Cancer|November 21, 2009
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissueS Corbetta, V Vaira, V Guarnieri, et al.Lung Cancer (Amsterdam, Netherlands)|December 31, 2005
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlationsA Destro, G L Ceresoli, M Falleni, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2015
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma modelA Lo Dico, C Martelli, S Valtorta, et al.International Journal of Cancer|January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumorsE Peverelli, E Giardino, D Treppiedi, et al.Pageof 1